Particularly at sections 101 and 102, which deal with residency slots, the use of provisions of regulations that we feel strongly that these would be a positive aspect to allow us to develop more residencesy programs in va to have the potential to recruit residents from those programs to provide care for veterans. I think also looking at section 300, which deals with additional provisions that put Network Directors and Medical Center directors under title 38 and allow us to be more competitive as we recruit in all localities and address complexity challenges that are facing a number of our locations, these are all going to be very positive actions that will help us i think be competitive in the Health Care Market today. Im going to join as a cosponsor of this measure. I think it is absolutely vital and i thank to thank senator tester for his leadership. Thank you, mr. Chairman. Senator rounds, followed by senator tester. Thank you, mr. Chairman. I just wanted to followup also on senato
Last week, NCPA hosted the intrepid members of its steering committees for the annual NCPA Steering Committee Forum some of the best and brightest pharmacy owners from around the country who spent two days helping NCPA keep its finger on the pulse of independent pharmacy. Coming off a productive annual convention in Orlando last month, attendees from six standing committees gathered at NCPA’s headquarters in Alexandria, Va., between Nov. 7 and Nov. 9.
Dear Colleague, There's a time for planning and there's a time for doing and one of the great things about NCPA's annual Steering Committee Forum is that it's a time for both.
The NCPA National Legislation Committee and the NCPA State Government Affairs Committee meet separately today to discuss recent legislative events and to come up with a legislative action plan for 2024. This has been a transformative year already for pharmacy with actions at the state level and the federal level that point the way to a bright future. This past June, the Senate heard about the NCPA-backed legislation called Protect Patient Access to Pharmacies Act.